Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.

about

Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.

Item

http://www.wikidata.org/entity/Q38630652

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Functional genetic variants of ...... egulating the gene expression.

@en

type

Item

label

Functional genetic variants of ...... egulating the gene expression.

@en

prefLabel

Functional genetic variants of ...... egulating the gene expression.

@en

P1476

Functional genetic variants of ...... regulating the gene expression

@en

P2093

Lei Cheng

http://www.w3.org/2001/XMLSchema#string

Lixin Qiu

http://www.w3.org/2001/XMLSchema#string

Menghong Sun

http://www.w3.org/2001/XMLSchema#string

Mengyun Wang

http://www.w3.org/2001/XMLSchema#string

Ruoxin Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaodong Zhu

http://www.w3.org/2001/XMLSchema#string

Yanong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The dynamics of Ku70/80 and DNA-PKcs at DSBs induced by ionizing radiation is dependent on the complexity of damage

A human XRCC4-XLF complex bridges DNA

A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients

Assessing the probability that a positive report is false: an approach for molecular epidemiology studies

Human DNA repair genes.

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.

An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.

CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients

P304

2706-2717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MC.22713

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jie-Yun Yin

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28796378

http://www.w3.org/2001/XMLSchema#string